[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:rectal-adenocarcinoma:msi1-gene":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Rectal Adenocarcinoma","MSI1 Gene",3,[8,16,22],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06843434","A Study of Botensilimab and Balstilimab for Rectal Adenocarcinoma",[12],"Phase 2","RECRUITING","2026-08-26T02:15:22.311223Z","2026-07-05T05:32:16.700719Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT05672524","A Study of Tucatinib and Trastuzumab in People With Rectal Cancer",[12],"2026-08-26T02:17:00.709807Z","2026-05-05T02:43:29.285490Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT06834126","Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE Trial",[26],"Phase 1","2026-08-26T02:18:45.196599Z","2026-05-05T02:35:31.903048Z"]